Pharming Articles
Pharming and Santarus file BLA for Ruconest with US FDA
18 April 2013
Pharming first-half 2012 net loss nearly doubles
24 August 2012
Pharming extends Ruconest deal with SOBI
16 August 2011
FDA turns down 'incomplete' Rhucin dossier
1 March 2011
Pharming licenses North American rights to HAE drug Rhucin to Santarus for upfront $15 million
14 September 2010
Pharming plans to file Rhucin BLA with US FDA by end 2010
31 August 2010
Batch of positive opinions from Europe's Committee for Medicinal Products for Human Use recent meetings
28 June 2010
Showing 1-13 of 13 articles
- 1
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Negative US patent ruling for Novo Nordisk on Prandin
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Daiichi Sankyo files for Japanese approval of Prasugrel
